AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARROWHEAD PHARMACEUTICALS, INC. Director's Dealing 2021

Dec 30, 2021

31071_dirs_2021-12-29_da09598d-8d1d-401b-be48-56e9218e6297.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2021-12-28

Reporting Person: Ferrari Mauro (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-28	Common Stock	S	3400	$66.82	Disposed	36571	Direct

Footnotes

F1: The sale was made to generate proceeds to cover the tax liability incident to an upcoming vesting of restricted stock units in January 2022.

F2: Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.